| Study | Design | Population | Duration | Primary Endpoint | Results | |-------|--------|------------|----------|------------------|---------| | (Phase III) | Randomized, double‑blind, parallel‑group | 2,184 pts with hypertension + LDL‑C ≥ 130 mg/dL | 24 weeks | Change in SBP & LDL‑C | SBP ↓ ‑12.3 mm Hg; LDL‑
Helps reduce widespread muscle aches and tenderness while improving sleep quality.
Mild improvement may be seen in 3–4 weeks; maximum benefit often requires 3 months.
Avinerve XT typically combines an anticonvulsant with nutritional supplements to provide multi-layered relief:
